IP Library Granted Patent US 12,232,801
Granted Patent B2
US 12,232,801 · App. 17/058,718 · Granted Feb 25, 2025

System and method for mitigating rising impedance via a pump assembly during use of cooled radiofrequency probes

Inventors: Ruoya Wang (Decatur, GA); Jennifer J. Barrett (Alpharetta, GA); Joseph DiPietro (Ponte Vedra, FL); Rasagnya M. Viswanadha (Cumming, GA); Tyler W. Crone (Atlanta, GA)
Assignee: Avent, Inc.
A61B18/148A61B2018/00023A61B2018/00077A61B2018/00083A61B2018/00095A61B2018/00339A61B2018/00434A61B2018/00577A61B2018/00589A61B2018/00678A61B2018/00797A61B2018/00875
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,232,801
App. No.
17/058,718
Granted
Feb 25, 2025
Kind
B2
Abstract

A method of treating tissue of a patient's body includes providing a power source coupled to at least one probe assembly. The probe assembly includes an elongate member with a distal region and a proximal region. The distal region has an electrically and thermally-conductive energy delivery device for delivering one of electrical and radiofrequency energy to the patient's body. The electrically and thermally-conductive energy delivery device has one or more internal lumens for circulating a cooling fluid therethrough and an electrically and thermally-conductive protrusion having a temperature sensing element. The temperature sensing element extends from a distal end of the energy delivery device. The method includes inserting the energy delivery device of the at least one probe assembly into the patient's body. Further, the method includes routing the energy delivery device of the at least one probe assembly to the tissue of the patient's body. The method also includes simultaneously circulating the cooling fluid through the one or more internal lumens via at least one pump assembly and delivering energy from the power source to the tissue through the energy delivery device. Further, the method includes monitoring one or more procedure parameters while delivering the energy from the power source to the tissue through the energy delivery device. Moreover, the method includes determining, in real-time, whether a rising impedance event is likely to occur in a predetermined time period based on the one or more procedure parameters and determining a command for the pump assembly based on whether the rising impedance event is likely to occur in the predetermined time period.

Claims (43)

1. A method of treating tissue of a patient's body, the method comprising:

providing a power source coupled to at least one probe assembly, the at least one probe assembly comprising an elongate member with a distal region and a proximal region, the distal region having an electrically and thermally-conductive energy delivery device for delivering one of electrical and radiofrequency energy to the patient's body, the electrically and thermally-conductive energy delivery device having one or more internal lumens for circulating a cooling fluid therethrough and an electrically and thermally-conductive protrusion having a temperature sensing element, the temperature sensing element extending from a distal end of the energy delivery device;

inserting the energy delivery device of the at least one probe assembly into the patient's body;

routing the energy delivery device of the at least one probe assembly to the tissue of the patient's body;

simultaneously circulating the cooling fluid through the one or more internal lumens via at least one pump assembly and delivering energy from the power source to the tissue through the energy delivery device;

monitoring one or more procedure parameters while delivering the energy from the power source to the tissue through the energy delivery device;

determining, in real-time, whether a rising impedance event is likely to occur in a predetermined time period based on the one or more procedure parameters including at least one of a temperature of the tissue, an impedance of the tissue, and a power demand of the energy delivery device;

responsive to determining that the rising impedance event is likely to occur in the predetermined time period, decreasing a flow rate of the at least one pump assembly; and

responsive to determining that the rising impedance event is unlikely to occur in the predetermined time period, increasing the flow rate of the at least one pump assembly up to a predetermined maximum flow rate or rotational speed.

2. The method of claim 1 , further comprising measuring the temperature of the tissue using the temperature sensing element.

3. The method of claim 2 , wherein the temperature sensing element comprises a length of less than about 1 millimeter (mm) that extends from the distal end of the energy delivery device.

4. The method of claim 1 , wherein the at least one pump assembly comprises at least one pump communicatively coupled to at least one control module.

5. The method of claim 4 , further comprising:

comparing the power demand of the energy delivery device to a predetermined threshold; and

if the power demand is greater than the predetermined threshold, decreasing a speed of the at least one pump; and

if the power demand is less than the predetermined threshold increasing the speed of the at least one pump up to the predetermined maximum flow rate or rotational speed.

6. The method of claim 4 , further comprising decoupling, at least in part, the control module of the at least one pump assembly from the power source.

7. The method of claim 1 , wherein delivering energy from the power source to the tissue through the energy delivery device further comprises:

defining a predetermined threshold temperature for treating the tissue;

ramping up a temperature of the tissue via the power source through the energy delivery device to the predetermined threshold temperature; and,

maintaining the temperature of the tissue at the predetermined threshold temperature to create a lesion in the tissue.

8. The method of claim 7 , further comprising maintaining the temperature of the tissue at the predetermined threshold temperature as a function of at least one of a power ramp rate, an impedance level, an impedance ramp rate, and/or a ratio of impedance to power.

9. The probe assembly of claim 7 , wherein the predetermined threshold temperature is determined based at least in part on historical testing data.

10. The probe assembly of claim 7 , wherein the predetermined threshold temperature is determined based at least in part on a preset profile corresponding with a desired lesion size.

11. A medical probe assembly for delivering energy to a patient's body, the probe assembly comprising:

at least one probe having an elongate member with a distal region and a proximal region, said distal region comprising an electrically non-conductive outer circumferential portion;

an electrically and thermally-conductive energy delivery device extending distally from said electrically non-conductive outer circumferential portion for delivering one of electrical and radiofrequency energy to the patient's body, said energy delivery device comprising a conductive outer circumferential surface and one or more internal lumens configured for circulating a cooling fluid to a distal end of said energy delivery device;

an electrically and thermally-conductive protrusion extending from said distal end of said energy delivery device, said electrically and thermally-conductive protrusion being electrically coupled to said energy delivery device, said electrically and thermally-conductive protrusion comprising a temperature sensing element;

at least one pump assembly for circulating the cooling fluid to and from the electrically and thermally-conductive energy delivery device;

one or more sensors for monitoring one or more procedure parameters including at least one of a temperature of the patient's tissue, an impedance of the tissue, and a power demand of the energy delivery device; and

a controller communicatively coupled to the one or more sensors, the controller comprises a rising impedance detection engine configured to perform operations comprising:

determining, in real-time, whether a rising impedance event is likely to occur in a predetermined time period based on the one or more procedure parameters,

responsive to determining that the rising impedance event is likely to occur in the predetermined time period, decreasing a flow rate of the at least one pump assembly, and

responsive to determining that the rising impedance event is unlikely to occur in the predetermined time period, increasing the flow rate of the at least one pump assembly up to a predetermined maximum flow rate or rotational speed.

12. The probe assembly of claim 11 , wherein the temperature sensing element is configured to measure the temperature of the tissue.

13. The probe assembly of claim 12 , wherein the temperature sensing element comprises a length of less than about 1 millimeter (mm) that extends from a distal end of the energy delivery device.

14. The probe assembly of claim 11 , wherein the at least one pump assembly comprises at least one pump communicatively coupled to at least one control module.

15. The probe assembly of claim 14 , wherein the at least one pump assembly comprises a plurality of pumps communicatively coupled to the at least one control module, each of the plurality of pumps in separate fluid communication with a different probe assembly.

16. The probe assembly of claim 11 , wherein the controller is further configured to compare the power demand of the energy delivery device to a predetermined threshold, and if the power demand is greater than the predetermined threshold, decrease the speed for the at least one pump, and if the power demand is less than the predetermined threshold, increase the speed for the at least one pump up to the predetermined maximum flow rate or rotational speed.

17. The probe assembly of claim 11 , wherein the one or more operations further comprise:

defining a predetermined threshold temperature for treating the tissue;

ramping up a temperature of the tissue via a power source through the energy delivery device to the predetermined threshold temperature; and,

maintaining the temperature of the tissue at the predetermined threshold temperature to create a lesion in the tissue.

Assignments (2)
SECURITY INTEREST Recorded Jun 24, 2022
From: AVENT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060441/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2020
From: WANG, RUOYA; BARRETT, JENNIFER J.; DIPIETRO, JOSEPH; VISWANADHA, RASAGNYA M.; CRONE, TYLER W.
To: AVENT, INC.
Reel/Frame 054465/0942 →
Continuity (2)
Provisional Application 62677714 · May 30, 2018
Related Publication 20210169556A1 · Jun 10, 2021
References Cited (56)
US 5437662A · Nardella · 1995 [cited by applicant]
US 6231570B1 · Tu et al. · 2001 [cited by applicant]
US 6413254B1 · Hissong et al. · 2002 [cited by applicant]
US 6425912B1 · Knowlton · 2002 [cited by applicant]
US 6575969B1 · Rittman, III et al. · 2003 [cited by applicant]
US 7048732B2 · Ellingsen · 2006 [cited by applicant]
US 7081111B2 · Svaasand et al. · 2006 [cited by applicant]
US 7108696B2 · Daniel et al. · 2006 [cited by applicant]
US 7160296B2 · Pearson et al. · 2007 [cited by applicant]
US 7201750B1 · Eggers et al. · 2007 [cited by applicant]
US 7247155B2 · Hoey et al. · 2007 [cited by applicant]
US 7344533B2 · Pearson et al. · 2008 [cited by applicant]
US 7771420B2 · Butty et al. · 2010 [cited by applicant]
US 7818854B2 · Wilson · 2010 [cited by applicant]
US 7976537B2 · Lieber et al. · 2011 [cited by applicant]
US 8764744B2 · Brannan · 2014 [cited by applicant]
US 8932288B2 · Leo et al. · 2015 [cited by applicant]
US 8971997B2 · Oral et al. · 2015 [cited by applicant]
US 9078680B2 · Lemberg et al. · 2015 [cited by applicant]
US 9138288B2 · Curley · 2015 [cited by applicant]
US 9326813B2 · Pike, Jr. et al. · 2016 [cited by applicant]
US 9333024B2 · Woloszko et al. · 2016 [cited by applicant]
US 9420955B2 · Weber · 2016 [cited by applicant]
US 9956032B1 · Cosman et al. · 2018 [cited by applicant]
US 20020111615A1 · Cosman · 2002 [cited by examiner]
US 20050107778A1 · Rioux · 2005 [cited by examiner]
US 20050177210A1 · Leung et al. · 2005 [cited by applicant]
US 20050177211A1 · Leung · 2005 [cited by examiner]
US 20050209578A1 · Christian Evans et al. · 2005 [cited by applicant]
US 20060200121A1 · Mowery · 2006 [cited by applicant]
US 20070078502A1 · Weber et al. · 2007 [cited by applicant]
US 20070287995A1 · Mayse · 2007 [cited by applicant]
US 20080009747A1 · Saadat et al. · 2008 [cited by applicant]
US 20090163807A1 · Sliwa · 2009 [cited by applicant]
US 20090287092A1 · Leo et al. · 2009 [cited by applicant]
US 20110077628A1 · Hoey et al. · 2011 [cited by applicant]
US 20110288540A1 · Wright et al. · 2011 [cited by applicant]
US 20120172858A1 · Harrison et al. · 2012 [cited by applicant]
US 20140081260A1 · Cosman, Jr. et al. · 2014 [cited by applicant]
US 20150105701A1 · Mayer et al. · 2015 [cited by applicant]
US 20150313699A1 · Darmos et al. · 2015 [cited by applicant]
US 20150320473A1 · Kalser et al. · 2015 [cited by applicant]
US 20160206370A1 · Fruland et al. · 2016 [cited by applicant]
US 20170020606A1 · Leung et al. · 2017 [cited by applicant]
US 20170065335A1 · Wright et al. · 2017 [cited by applicant]
US 20180078170A1 · Panescu et al. · 2018 [cited by applicant]
EP 2875791A1 · 2015 [cited by applicant]
EP 1493397B2 · 2015 [cited by applicant]
GB 2210560A · 1989 [cited by applicant]
WO WO9904710A1 · 1999 [cited by applicant]
WO WO0133165A1 · 2001 [cited by applicant]
WO WO2006021095A1 · 2006 [cited by applicant]
WO WO2018067496A1 · 2018 [cited by applicant]
International Search Report and Written Opinion for PCT/US2019/034164, dated Jul. 31, 2019, 14 pages. [cited by applicant]
International Preliminary Report on Patentability issued in PCT/US2019/034164 on Dec. 1, 2020, 8 pages. [cited by applicant]
Examination Report issued in Australian Application No. 2019277125 on May 3, 2024, 4 pages. [cited by applicant]